Menu Search
Equities

Demant A/S

DEMANT:CPH

Demant A/S

Actions
Health CareMedical Equipment and Services
  • Price (DKK)335.00
  • Today's Change4.00 / 1.21%
  • Shares traded325.14k
  • 1 Year change+19.47%
  • Beta1.5346
Data delayed at least 15 minutes, as of May 17 2024 16:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in DKKIncome statement in DKKView more

Year on year Demant A/S had net income fall -13.78% from 2.08bn to 1.80bn despite a 13.89% increase in revenues from 19.71bn to 22.44bn.
Gross margin73.72%
Net profit margin11.38%
Operating margin18.48%
Return on assets8.46%
Return on equity28.65%
Return on investment12.20%
More ▼

Cash flow in DKKView more

In 2023, Demant A/S did not generate a significant amount of cash. However, the company earned 4.27bn from its operations for a Cash Flow Margin of 19.03%. In addition the company used 1.79bn on investing activities and also paid 2.44bn in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share41.97
Tangible book value per share-19.42
More ▼

Balance sheet in DKKView more

Demant A/S has a Debt to Total Capital ratio of 60.75%, a lower figure than the previous year's 91.86%.
Current ratio1.37
Quick ratio0.9529
Total debt/total equity1.56
Total debt/total capital0.6075
More ▼

Growth rates in DKK

Growth rate information is not available.
EPS growth(5 years)9.34
EPS (TTM) vs
TTM 1 year ago		13.68
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.